EyePoint Pharmaceuticals, Inc.EYPTNASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, below historical average.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-145.85M
↓ 180% below average
Average (9y)
$-52.12M
Historical baseline
Range
High:$6.42M
Low:$-145.85M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-145.85M | -94.3% |
| 2023 | $-75.07M | +24.7% |
| 2022 | $-99.64M | -80.3% |
| 2021 | $-55.28M | -48.2% |
| 2020 | $-37.29M | +22.1% |
| 2019 | $-47.86M | -82.2% |
| 2018 | $-26.27M | -41.4% |
| 2017 | $-18.58M | +14.7% |
| 2016 | $-21.77M | -439.1% |
| 2015 | $6.42M | - |